Channel ushering drug common achyranthes-containing traditional Chinese drug composition for improving bone marrow stem cell homing

Abstract

The present invention provides a channel ushering drug common achyranthes-containing traditional Chinese drug composition for improving bone marrow stem cell homing. The traditional Chinese drug composition is prepared from the following raw material drugs, wherein the raw material drugs comprise, by weight, 10-20 parts of common achyranthes, 15-45 parts of mongolian milkvetch root, 10-20 parts of angelica, 10-20 parts of szechwan lovage rhizome, 6-18 parts of red peony root, 10-20 parts of peach seed, 10-20 parts of safflower, 10-20 parts of lumbricus, 10-20 parts of cassiabarktree twig, 10-20 parts of common floweringquine fruit, and 10-20 parts of clematis chinensis osbeck. According to the present invention, the channel ushering drug common achyranthes-containing traditional Chinese drug composition of the present invention has the effect of improvement of autologous bone marrow stem cell homing so as to improve bone repair and vascular regeneration inside the femur head, and provides significant effects for delaying of disease developments of femur head necrosis and other osteoarticular diseases. In addition, the traditional Chinese drug composition has characteristics of lowtoxic and side-effects and low price.

Description

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine

Login to view more

AI Technical Summary

Benefits of technology

This invention relates to an effective treatment method that uses chinese herbs called achillea (Cynomorium songaricum) which helps heal damaged parts by stimulating new growths from existing ones. It can also help promote nerve regeneration through its ability to release nitric oxide or other substances like histamine into surrounding areas around it's own roots.

Problems solved by technology

The technical problem addressed in this patented study relates to improving the efficiency and accuracy of treatments involving bone marrow dysfunction associated with knee joint pain syndrome. Current options involve either traditional stromaferential graft techniques or mesenchymaphysevitus arthropathy transfer technique(MTA). These procedures may result in complications such as inflammations and fibrocartilage tissue formation around the damaged area during healing process. Additionally, current approaches like biological agents used alone cannot achieve complete recovery from these conditions without causing further damage.

Images